The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU Hematology & Medical Oncology Review 2019
Avatar

KU ASCO 2019 Updates on Trial Discussing Nivolumab + Ipilimumab in Melanoma Brain Metastases

By KU Hematology & Medical Oncology Review 2019 FEATURING Gary Doolittle
By KU Hematology & Medical Oncology Review 2019 FEATURING Gary Doolittle
0 views
August 22, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou
Skin
12:46
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Update on Surgical Treatment of Melanoma & Adjuvant…

Feat. G. Doolittle
07:50
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates on Trial Discussing Nivolumab + Ipilimumab in M…

Feat. G. Doolittle
08:44
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Long-Term Survival of Dabrafenib Plus Trametinib in Met…

Feat. G. Doolittle